FR1453897A - Dérivés du thiophène et de thiéno pyridazines - Google Patents

Dérivés du thiophène et de thiéno pyridazines

Info

Publication number
FR1453897A
FR1453897A FR20979A FR20979A FR1453897A FR 1453897 A FR1453897 A FR 1453897A FR 20979 A FR20979 A FR 20979A FR 20979 A FR20979 A FR 20979A FR 1453897 A FR1453897 A FR 1453897A
Authority
FR
France
Prior art keywords
thienopyridazine
thiophene
derivatives
thienopyridazine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR20979A
Other languages
English (en)
Inventor
Max Fernand Robba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR20979A priority Critical patent/FR1453897A/fr
Application granted granted Critical
Publication of FR1453897A publication Critical patent/FR1453897A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR20979A 1965-06-16 1965-06-16 Dérivés du thiophène et de thiéno pyridazines Expired FR1453897A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR20979A FR1453897A (fr) 1965-06-16 1965-06-16 Dérivés du thiophène et de thiéno pyridazines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR20979A FR1453897A (fr) 1965-06-16 1965-06-16 Dérivés du thiophène et de thiéno pyridazines

Publications (1)

Publication Number Publication Date
FR1453897A true FR1453897A (fr) 1966-07-22

Family

ID=8582160

Family Applications (1)

Application Number Title Priority Date Filing Date
FR20979A Expired FR1453897A (fr) 1965-06-16 1965-06-16 Dérivés du thiophène et de thiéno pyridazines

Country Status (1)

Country Link
FR (1) FR1453897A (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2463145A1 (fr) * 1979-08-07 1981-02-20 Sanofi Sa Thieno(2,3-d)pyridazines, leur procede de preparation et leur application en therapeutique
FR2478640A1 (fr) * 1980-03-24 1981-09-25 Sanofi Sa Nouvelles thieno (2,3-d) pyridazinones-4 et thieno (2,3-d) pyridazinones-7, leur procede de preparation et leur therapeutique
WO1991012251A1 (fr) * 1990-02-19 1991-08-22 Chugai Seiyaku Kabushiki Kaisha Nouveau compose heterocyclique condense et agent anti-asthme prepare a partir de ce compose
WO1999029695A1 (fr) * 1997-12-05 1999-06-17 Astrazeneca Uk Limited Nouveaux composes
WO2001023375A3 (fr) * 1999-09-28 2002-05-02 Bayer Ag Pyridines et pyridazines substituees a activite inhibitrice de l'angiogenese
US6579882B2 (en) 1998-06-04 2003-06-17 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
US6689883B1 (en) 1999-09-28 2004-02-10 Bayer Pharmaceuticals Corporation Substituted pyridines and pyridazines with angiogenesis inhibiting activity
US7977333B2 (en) 2000-04-20 2011-07-12 Bayer Healthcare Llc Substituted pyridines and pyridazines with angiogenesis inhibiting activity
EP2994128A4 (fr) * 2013-05-10 2016-11-23 Nimbus Apollo Inc Inhibiteurs de l'acc et utilisations associées
US9988399B2 (en) 2013-05-10 2018-06-05 Gilead Apollo, Llc Bicyclic compounds as ACC inhibitors and uses thereof
US10208044B2 (en) 2013-05-10 2019-02-19 Gilead Apollo, Llc ACC inhibitors and uses thereof
US10208063B2 (en) 2013-05-10 2019-02-19 Gilead Apollo, Llc ACC inhibitors and uses thereof
EP4279074A1 (fr) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Composés azolo pour le traitement de maladies fibrotiques

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2463145A1 (fr) * 1979-08-07 1981-02-20 Sanofi Sa Thieno(2,3-d)pyridazines, leur procede de preparation et leur application en therapeutique
FR2478640A1 (fr) * 1980-03-24 1981-09-25 Sanofi Sa Nouvelles thieno (2,3-d) pyridazinones-4 et thieno (2,3-d) pyridazinones-7, leur procede de preparation et leur therapeutique
WO1991012251A1 (fr) * 1990-02-19 1991-08-22 Chugai Seiyaku Kabushiki Kaisha Nouveau compose heterocyclique condense et agent anti-asthme prepare a partir de ce compose
WO1999029695A1 (fr) * 1997-12-05 1999-06-17 Astrazeneca Uk Limited Nouveaux composes
US6342601B1 (en) 1997-12-05 2002-01-29 Astrazeneca Ab Compounds
US6770646B2 (en) 1997-12-05 2004-08-03 Astrazeneca Ab Substituted fused pyridazinone compounds; composition and use thereof
US6579882B2 (en) 1998-06-04 2003-06-17 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
CZ304767B6 (cs) * 1999-09-28 2014-10-08 Bayer Corporation Substituovaný pyridin a pyridazin, farmaceutická kompozice s jeho obsahem a použití
WO2001023375A3 (fr) * 1999-09-28 2002-05-02 Bayer Ag Pyridines et pyridazines substituees a activite inhibitrice de l'angiogenese
US6689883B1 (en) 1999-09-28 2004-02-10 Bayer Pharmaceuticals Corporation Substituted pyridines and pyridazines with angiogenesis inhibiting activity
CN100374435C (zh) * 1999-09-28 2008-03-12 拜尔药品公司 具有血管生成抑制活性的取代的哒嗪
JP4919567B2 (ja) * 1999-09-28 2012-04-18 バイエル・コーポレーシヨン 脈管形成抑制活性を有する置換されたピリジン類およびピリダジン類
US7977333B2 (en) 2000-04-20 2011-07-12 Bayer Healthcare Llc Substituted pyridines and pyridazines with angiogenesis inhibiting activity
EP2994128A4 (fr) * 2013-05-10 2016-11-23 Nimbus Apollo Inc Inhibiteurs de l'acc et utilisations associées
US9765089B2 (en) 2013-05-10 2017-09-19 Gilead Apollo, Llc ACC inhibitors and uses thereof
US9988399B2 (en) 2013-05-10 2018-06-05 Gilead Apollo, Llc Bicyclic compounds as ACC inhibitors and uses thereof
AU2014262546B2 (en) * 2013-05-10 2018-11-08 Gilead Apollo, Llc ACC inhibitors and uses thereof
US10208044B2 (en) 2013-05-10 2019-02-19 Gilead Apollo, Llc ACC inhibitors and uses thereof
US10208063B2 (en) 2013-05-10 2019-02-19 Gilead Apollo, Llc ACC inhibitors and uses thereof
EP4279074A1 (fr) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Composés azolo pour le traitement de maladies fibrotiques
WO2023222865A1 (fr) * 2022-05-19 2023-11-23 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Composés azolo pour le traitement de maladies fibrotiques
EP4559521A3 (fr) * 2022-05-19 2025-08-06 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Composés azolo pour le traitement de maladies fibrotiques

Similar Documents

Publication Publication Date Title
CH421025A (de) Unterhose
CH453615A (de) Badewanne
FR1509373A (fr) Dérivés d'amino-3-aryloxindole
FR1533184A (fr) Dérivés du thiazole
OA01933A (fr) Dérivés du thiazole.
FR1496442A (fr) Circuits de temporisation
FR1492077A (fr) Dérivés de la dibenzothiazine
FR1509940A (fr) Dérivés alkéniques
FR1505356A (fr) Dérivés du dibenzocycloheptadiène et leur préparation
BR6681072D0 (pt) Derivados de alqueno
FR1476558A (fr) Thiazolylthiobenzimidazoles et thiazolylsulfinylbenzimidazoles
FR1491438A (fr) Paumelles
FR1423898A (fr) Gabarits de formage et de traçage
FR1478335A (fr) Alambic perfectionné
FR1543973A (fr) Diisocyanates et dérivés
FR1508322A (fr) Dérivés des benzylthiobenzimidazoles
FR1440245A (fr) Nouveaux adamant-1-yl-glyoxals et leurs dérivés fonctionnels
FR1446444A (fr) Couche-culotte
FR1479165A (fr) Dérivés dodécatriéniques
FR1447333A (fr) Châssis perfectionné
FR1474858A (fr) Dérivés du cyclobutyl-acrylonitrile et leur préparation
FR1479962A (fr) Dérivés du 1-hydroxy-oestradiol et leur préparation
FR1538362A (fr) Dérivés du benzomorphane
FR1484455A (fr) Polyisocyanatosilanes et polyisocyanatosiloxanes
FR1488318A (fr) Dérivés sulfénylés de vinylbenzimidazoles